福瑞医科股价涨5.17%，红土创新基金旗下1只基金重仓，持有15.77万股浮盈赚取57.4万元

Group 1 - The core viewpoint of the news is that Furuimei Medical has seen a stock price increase of 5.17%, reaching 74.05 yuan per share, with a trading volume of 291 million yuan and a turnover rate of 1.73%, resulting in a total market capitalization of 19.621 billion yuan [1] - Furuimei Medical, established on December 26, 2001, and listed on January 20, 2010, is primarily engaged in the production and sales of drugs in the liver disease sector, as well as instrument research and sales, and medical services [1] - The revenue composition of Furuimei Medical includes 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Group 2 - According to data from the top ten holdings of funds, Hongtu Innovation Fund holds a significant position in Furuimei Medical, with 157,700 shares, accounting for 4.32% of the fund's net value, making it the ninth largest holding [2] - The Hongtu Innovation Healthcare Stock Fund (010434) has a current scale of 272 million yuan and has achieved a year-to-date return of 27.97%, ranking 1956 out of 4189 in its category [2] - The fund manager, Liao Xinghao, has been in position for 4 years and 45 days, with the fund's total assets amounting to 804 million yuan, achieving the best return of 81.61% and the worst return of -3.87% during his tenure [2]